Ontologies in quantitative biology: a basis for comparison, integration, and discovery by Jensen, L.J. & Bork, P.
Essay
Ontologies in Quantitative Biology: A Basis for
Comparison, Integration, and Discovery
Lars J. Jensen1*, Peer Bork2,3*
1Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark, 2 European Molecular Biology
Laboratory, Heidelberg, Germany, 3Max Delbru¨ck Center for Molecular Medicine, Berlin-Buch, Germany
Biology is rapidly changing from a
descriptive to a data-driven discipline in
which the discovery of novel findings
depends on the comparison and integra-
tion of massive data sets. As a conse-
quence, ontologies—systematic descrip-
tions of specific biological attributes—are
becoming more and more important for
describing the existing biological knowl-
edge. Despite an increasing awareness
about ontologies among biologists, much
work remains to be done before many
research fields in biology can benefit from
capturing the knowledge in such a way.
We explore, here, the use of biological
ontologies, illustrate how ontologies can be
used to make discoveries, and discuss some
of the challenges to using ontologies for
more than descriptive purposes.
The word ontology is derived from Greek
o¨ntoz (of being) and -locı´a, (study) and
refers to the philosophical study of the
nature of being and existence. In comput-
er science, an ontology is an explicit
specification of a conceptualization that
defines the objects, concepts, and other
entities that are presumed to exist in some
area of interest and the relationships that
hold among them [1].
Ontologies have a long tradition in
biology and medicine, although many of
them are normally referred to as taxono-
mies or classifications. A very early
example of a biological ontology is the
Linnaean taxonomy from the mid 1700s,
which describes relations between species
and, combined with the work of Charles
Darwin, forms the basis for modern
taxonomy and our understanding of
evolution. Today, ontologies have become
an essential part of modern molecular
biology, enabling large-scale comparison,
integration, and sharing of data. Many of
the early ontologies are usually not
thought of as ontologies or formally
specified in ontological terms, yet they
form the conceptual basis of molecular
biology. For example, they focus on
classification of and relationships between
biological entities or concepts such as
amino acids [2] and protein structures
[3,4], protein and domain families [5–7],
as well as associated molecular functions
[7,8] and biochemical pathways [9].
The Rising Awareness About
Biomedical Ontologies
The ontologies mentioned above are all
fairly simple classification schemes that
consist of either a single level of categories
or a hierarchy of categories (i.e., a tree
structure). One of the most well-known
ontologies, Gene Ontology (GO), inte-
grates model organism databases to pro-
vide descriptions of gene products across
organisms using standardized, machine-
readable language. To tackle the problem
of describing protein functions in their
cellular context, GO uses a more complex
structure known as directed acyclic graph
(DAG) [10]. The difference between a tree
and a DAG is that in the latter a term can
be related to multiple broader terms rather
than only one (Figure 1). This allows GO
to elegantly model, for example, that
receptor tyrosine kinases are both receptors and
kinases.
GO has had a major impact on the
awareness and use of ontologies in biology.
Prior to publication of GO in 2000 [10],
less than one in 10,000 new abstracts
added to Medline would mention the
words ontology or ontologies. By 2007 that
number had increased by more than an
order of magnitude, and more than two
thirds of the abstracts that mention
ontologies specifically mention GO
(Figure 2), which is also reflected in the
steady rise in the number of the citations
to GO and associated resources. This can,
in part, be attributed to the use of GO
within rapidly growing research areas such
as comparative genomics, transcriptomics,
and proteomics. Another important con-
tribution is that the GO consortium
worked closely together with the commu-
nities behind key model organism data-
bases to ensure that vast amounts of GO-
based annotations would be provided for
each of the respective genomes.
An ontology is much like a database:
until it is used to organize actual data, it is
an empty shell that is not of much use to
anyone. Once large amounts of data are
easily accessible in a structured form,
numerous tools will almost certainly be
designed to make use of it. Indeed, half of
the top 10 cited papers related to the topic
ontologies present tools that allow easy
statistical analysis and inspection of GO
terms for a set of genes or proteins, for
example, identified in a transcriptomics or
proteomics study [11–15]. As a direct
consequence, GO is one of the few
ontologies that are frequently used to
describe and compare large-scale datasets
and have succeeded in revealing trends
that might otherwise have been over-
looked. For example, GO analysis sug-
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gested that translational repression is
stronger for mRNAs translated by endo-
plasmic-reticulum-associated ribosomes
compared to free cytosolic ribosomes
[16]. Going beyond convenient overviews
and utilizing ontologies to reveal new
biological insights remains one of the
major challenges. So far, most efforts to
enhance ontologies are directed at broad-
ening the biological knowledge that is
formalized using ontologies.
Recently, interaction ontologies have
been developed that complement the
current GO scheme on functional classifi-
cations. These ontologies aim to describe
the types of interactions that can take
place between biomolecules, including
binding, regulation, and modification
[17–20]. GO has taken the first small step
in this direction by adding new relation-
ship types related to regulation [21].
Numerous other biomedical ontologies
are being developed that are useful for
providing context for the functions of
genes, proteins, and small molecules.
Furthermore, ontologies cover complex
biological processes and systems such as
anatomy, development, and phenotypes.
In medicine, ontologies such as Medical
Subject Headings (MeSH), International
Classification of Diseases (ICD), Systema-
tized Nomenclature of Medicine–Clinical
Terms Diseases (SNOMED-CT), Ana-
tomical Therapeutic Chemical (ATC)
classification system, and Coding Symbols
for Thesaurus of Adverse Reaction Terms
(COSTART) are extensively used to
classify diseases, symptoms, drugs, and
side effects. Currently, about 200 biomed-
ical ontologies are listed in databases like
http://www.bioontology.org/ and http://
www.obofoundry.org/. Yet, there are
obvious areas such as the interaction of
species with the environment (e.g., life-
styles and habitat similarities) where first
attempts have been made (http://www.
environmentontology.org), but which de-
serve more attention in the future.
Using Ontologies for Discovery
In addition to having important roles in
genome annotation and statistical character-
ization of gene sets, ontologies have the
potential to help scientists make new discov-
eries. To our knowledge, this potential has
only been realized in a few case studies so far.
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Figure 1. Typical structures of ontologies. Almost all biomedical ontologies are either simple tree structures that represent hierarchical
classifications or directed acyclic graphs (DAGs). The difference is that the latter allows a term to be related to multiple broader tems (green arrows)
whereas the former does not. Directed cyclic graphs are very rarely used for ontologies; the reason is that cycles (red arrows) can only arise in
ontologies that make use of other relationships than is-a and part-of are used [28]. We illustrate each structure with simplified examples, namely an
ontology of vertebrates, an ontology of cellular components, and an ontology of cell-cycle regulation that shows the mutual regulation of cyclin-
dependent kinase (CDK) and anaphase-promoting complex/cyclosome (APC/C).
doi:10.1371/journal.pbio.1000374.g001
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An early example is the Genes2Diseases
method [22], which predicts candidate
genes for inherited diseases in a given
locus by correlating molecular functions of
the genes therein assigned by GO with
controlled vocabularies in chemistry, dis-
eases and phenotypes provided by the
Medical Subject Headings in Medline
(MeSH terms). For example, the gluta-
mate dehydrogenase 1 and 2 genes, which
reside within the linkage region of the
disease spinocerebellar ataxia-8, infantile, with
sensory neuropathy, were predicted to be
involved in the disease based on literature
links between the GO term glutamate
catabolism and the MeSH term spinocerebellar
degenerations.
Recently, two new uses of ontologies for
discovery have been published. The first
links human diseases to animal models
through cross-species comparison of phe-
notypes and anatomical structures [23],
and the second identifies hitherto un-
known targets for existing drugs by
comparing side effects [24]. Despite the
completely different goals, the two meth-
ods conceptually have much in common:
concepts (be they diseases, animal models,
or drugs) are linked based on the similarity
of the sets of phenotypes that they are
associated with. The phenotypes are
described using terms from ontologies,
which are backtracked to broader, paren-
tal terms in the ontology (see Figure 3).
Finally, the resulting sets of phenotypes are
compared using scoring schemes that take
into account the frequencies of the term,
because rare terms are generally more
informative than very common terms.
There is one main conceptual difference
between the two approaches. Washington
et al. needed to compare phenotypes
across species-specific anatomical ontolo-
gies to identify genes in model organisms
that are phenotypically similar to 11
human diseases [23]. By contrast, Cam-
pillos et al. could directly compare the
phenotypic side-effect profiles of different
drugs, because all side-effect data were
directly obtained from human subjects,
and thereby identify 261 pairs of chemi-
cally dissimilar drugs from different ther-
apeutic indications that are likely to share
targets [24].
These approaches go beyond the type of
logical reasoning that is usually associated
with ontologies. The major difference is
that they can identify plausible relation-
ships that are supported by the existing
knowledge, but which are not strict, logical
consequences thereof [25]. For example, a
human disease can be linked to an animal
model based on having similar annotated
phenotypes. The underlying idea that a
computer can discover a new, previously
unknown relationship (A–B) based on two
or more known relationships (A–C and B–
C) is reminiscent of the early (mostly
manual) text-mining work by Don Swan-
son who, for example, correctly predicted
that fish oil can ameliorate Raynaud
disease based on both concepts being
linked to platelet inhibition, vasodilation,
lowered blood viscosity and triglyceride
levels, increased prostacyclin, and blocking
of serotonin release [26]. In other words,
the phenotypic profile of the response to
fish oil matched that of successful treat-
ments of the disease.
Current Challenges and Future
Needs
The works described in the previous
section illustrate the promise of using
ontologies for biomedical research, but
also highlight some of the many challenges
that must be overcome if we are to realize
the power of ontologies and to move
beyond descriptions to discoveries. Despite
basing their work on existing ontologies,
both discovery projects involved a consid-
erable investment of time in annotating
the current knowledge within the field
(domain knowledge) according to the
ontologies. Although this annotation pro-
cess was aided by the use of text-mining
tools, domain experts must check all the
extracted facts. Quantity and quality of
annotation is, as alluded to earlier, the
make or break of any ontology.
A prerequisite for making good annota-
tions is that the human annotators use the
terms from the ontology consistently. It is
thus crucial to have clear definitions of all
the terms. The sequence ontology (SO) is so
far the only biological ontology to formally
specify the meaning of terms [27]. Al-
though formal definitions are certainly
more stringent than the textual descriptions
that all other biological ontologies rely on,
we believe that the latter are more
important for ensuring consistency of how
the terms are used by annotators.
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Figure 2. The growth of ontologies in biomedicine. To illustrate the increasing use of
ontologies, we mined PubMed abstracts for occurrences of the words ontology and gene ontology
(and the plural forms thereof). We normalized for the general growth of PubMed by converting
the raw counts per year to ‘‘hits per million abstracts.’’ The plot shows a steady increase in the
awareness of ontologies over the past decade, and that GO became the dominating biological
ontology over a period of just five years (note the logarithmic scale). However, ontologies appear
to have reached a plateau over in the past three years, at least in terms of how often they are
mentioned in abstracts. In contrast, the citations to GO and associated resources are steadily
rising (end of 2009.5500) and imply a further increasing use.
doi:10.1371/journal.pbio.1000374.g002
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Widely used ontologies like GO tend to
run into a second problem that only
enhances the former one: concept explo-
sion. GO currently consists of over 30,000
different terms, which makes it nearly
impossible for a human annotator to know
all terms, their precise definitions, and how
terms relate to each other. For example,
one could easily be mistaken to think that
the GO term DNA replication would auto-
matically imply the term cell cycle, but that is
not the case because some DNA replication
proteins are used only in the mitochondria
or in response to DNA damage. Nonethe-
less, there are many examples of cell-cycle
genes in the model organisms that are
annotated with the former GO term but
not the latter, which simply shows that even
the best database curators cannot be
expected to memorize a DAG of more
than 30,000 terms. Whereas complex
ontologies allow more fine-grained annota-
tions to be made, we suspect that simpler
ontologies may lead to fewer mistakes.
GO’s success can partly also be attrib-
uted to its consistent use of the same
ontology across species, which facilitates
simple similarity-based function annota-
tion and cross-species comparisons. How-
ever, it is a major challenge to accommo-
date species-specific differences within a
single ontology. This is especially true
when dealing with concrete physical
entities; for example, budding yeast and
humans do not have the same comple-
ment of protein complexes, which makes it
difficult to define a unified set of protein
complexes within the GO cellular compo-
nent ontology. This issue only becomes
more difficult when dealing with anatomy
or developmental stages, for which species-
specific ontologies are currently used. In
such cases the way forward may be to
bridge the species-specific ontologies by
identifying orthologous genes, that is,
genes from different species with common
ancestry, as was done by Washington and
colleagues [23].
The two largest challenges, though, are
that the vast majority of the biological
knowledge currently exists only as unstruc-
tured text, and that much of what is
described in a typical publication cannot
be captured by current ontologies. At best,
current ontologies describe the type of
information that would be given in the
Conclusions section of a paper. However,
the most important details typically reside
in the Results and Methods sections: which
observations were made and under which
exact conditions. To capture this in a
structured form, which will be crucial for
interpreting the future flood of experimen-
tal data, we will need ontologies such as the
Ontology for Biomedical Investiga-
tions (http://www.obi-ontology.org) that
are more closely tied to the experiments
and measurements themselves, rather than
to the researchers’ interpretations thereof.
Maintaining such ontologies will be partic-
ularly difficult because new experimental
techniques are continuously developed,
making a comprehensive description of
them a moving target. Even with such
ontologies in place, the challenge remains
to get the information described according
to ontologies. This will likely require the
development of tools that will help authors
annotate the text as they write it, and
possibly readers to subsequently improve
the annotations as the ontologies them-
selves are expanded (Box 1).
The need for computer-readable ways to
express our knowledge is closely tied to the
exponential growth in biological data.
Human-readable textual descriptions suf-
fice when analyzing only a few genes or
proteins, but computer-readable ontologies
are a prerequisite for systematic and
comparative analysis of whole genomes,
transcriptomes, or proteomics. Despite
these challenges, the rapid move towards
quantitative biology will thus likely drive
the development of new biological ontolo-
gies. The sheer number of high-throughput
experiments implies that ontologies will be
needed for describing not just the genes and
proteins but also information about the
samples and experiments themselves (i.e.,
metadata). Finally, current ontologies are
qualitative in nature, whereas ontologies
that can capture quantitative knowledge
(e.g., fold-changes) in time, space, and
context (e.g., environmental factors) will
be needed to fully describe the conclusions
derived from quantitative experiments.
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Figure 3. Ontology subsumption reasoning. This example from Washington et al. [23]
shows the relationships of the term ‘‘intestinal epithelium’’ to other anatomical entities within the
ZFA ontology. Gray arrows with an ‘‘i’’ indicate an is-a relation, and blue arrows with a ‘‘p’’ indicate
a part-of relation. The numbers indicate IC of the node, which is the negative log of the
probability of that description being used to annotate a gene, allele, or genotype (collectively
called a feature). As terms get more general, reading from bottom to top, they have a lower IC
score because the more general terms subsume the annotations made to more specific terms.
doi:10.1371/journal.pbio.1000374.g003
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Box 1. Semantic Annotation of Scientific Publications
To capture the knowledge of a publication in computer-readable form, the text must somehow be semantically annotated, that
is, the meaning of the text must be described using standardized names and terms.
Why? The biomedical literature is growing exponentially, and we are already past the point where it is impossible to read all
papers published on topics such as the cell cycle [29,30]. Reading thus needs to be supported by semantically enhanced
literature and ontology-aware tools that provide computational access to the underlying knowledge [30].
What? It is unclear how much of the meaning of an article should be captured by semantic annotation. Although more is
always better, it is important to keep in mind that anything is better than nothing. We should thus already now start to
annotate the genes, proteins, functions, interactions, and phenotypes mentioned in each publication with their respective
database identifiers and ontology terms. The scope of semantic annotations should subsequently be gradually extended as
new ontologies are developed.
Who? One option is to have authors annotate their manuscripts, since they know better than anyone exactly what was meant.
However, one cannot expect authors to be sufficiently well versed in ontologies to be able to make all the applicable
annotations, for which reason they may need support from database curators. The latter could also contribute annotations
directly; it would be desirable that the large effort that goes into constructing biological databases would also improve the
annotation of the underlying literature. Finally, one could allow readers to add and correct annotations.
When? One can envisage several points during the life cycle of an article when annotations could be added. Authoring tools
could help researchers annotate the text with appropriate ontology terms while writing the manuscript, which as an attractive
side-effect would encourage consistent usage of scientific terms in the text itself. Semantic annotation could alternatively
become part of turning an accepted manuscript into a publication. However, the annotation process need not end at the time
of publication; readers could correct erroneous or missing annotations and extend the scope of annotation in already published
articles as new ontologies are developed.
Where? There are several options as to where the semantic annotation of a publication could be stored. One option is to
embed it directly in the documents. This ensures the tightest possible link between text and annotation but would force the
annotations to be static, unless one allows post-publication changes to documents. Alternatively, annotations could be stored
in centralized databases operated by publishers or public information centers, or in a distributed manner that leaves the
individual content consumers to decide which types and sources of annotations to include.
The answers to these questions are obviously not independent of each other, and the alternative approaches are
complementary rather than mutually exclusive. Several different approaches have already been tested, often in collaboration
with publishers, and it is clear that tools will be required to ease the burden of manual annotation by suggesting semantic
annotations where appropriate (see [31] and references within).
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